| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.42M | 30.48M | 26.30M | 26.79M | 15.24M | 24.43M |
| Gross Profit | 5.22M | 10.43M | 10.14M | 9.61M | 4.99M | 9.85M |
| EBITDA | 2.40M | 1.50M | 0.00 | -3.02M | 4.85M | 7.42M |
| Net Income | 635.00K | 893.00K | 933.00K | -3.12M | 3.68M | 5.70M |
Balance Sheet | ||||||
| Total Assets | 71.93M | 73.98M | 71.87M | 62.48M | 68.44M | 57.41M |
| Cash, Cash Equivalents and Short-Term Investments | 31.21M | 30.80M | 30.36M | 23.71M | 35.78M | 31.52M |
| Total Debt | 11.88M | 11.76M | 13.73M | 10.38M | 13.38M | 7.98M |
| Total Liabilities | 30.89M | 32.54M | 31.39M | 23.32M | 26.22M | 18.48M |
| Stockholders Equity | 41.04M | 41.44M | 40.47M | 39.16M | 42.22M | 38.93M |
Cash Flow | ||||||
| Free Cash Flow | 7.67M | 2.53M | -1.39M | 7.50M | 2.88M | 630.00K |
| Operating Cash Flow | 7.67M | 2.53M | -1.39M | 7.50M | 2.88M | 630.00K |
| Investing Cash Flow | -6.51M | 22.00K | 16.00K | -5.81M | -6.47M | -5.89M |
| Financing Cash Flow | -730.00K | -3.31M | 2.19M | -3.32M | 4.70M | -1.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £165.56M | 9.55 | 56.75% | 5.98% | 16.29% | 22.80% | |
66 Neutral | £316.29M | 27.81 | 4.01% | 2.31% | 6.90% | 145.00% | |
64 Neutral | £434.04M | -12.59 | 9.00% | ― | -4.87% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | £102.95M | 7.60 | 5.86% | 8.80% | 6.04% | -24.55% | |
52 Neutral | £26.07M | -20.02 | 1.56% | ― | -4.67% | 590.48% |
Manolete Partners has granted nominal-cost share options to its senior leadership, including performance share awards of 200,000 shares each to Chief Executive Officer Philomena (Mena) Halton and Chief Financial Officer William Sawyer, and a 196,875-share restricted award to Halton recognising her recent promotion. The performance awards will vest after three years subject to earnings-per-share and share price hurdles, while most of Halton’s restricted shares are exercisable immediately with the balance vesting in 2026, underlining the company’s use of equity-based incentives to align management with shareholder value and support its leadership transition.
The most recent analyst rating on (GB:MANO) stock is a Buy with a £130.00 price target. To see the full list of analyst forecasts on Manolete Partners Plc stock, see the GB:MANO Stock Forecast page.